{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:05:48Z","timestamp":1791187548987,"version":"4.1.0"},"reference-count":13,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.parkreldis.2011.10.019","type":"journal-article","created":{"date-parts":[[2011,11,22]],"date-time":"2011-11-22T14:25:00Z","timestamp":1321971900000},"page":"397-399","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Role of genetic polymorphisms of the dopaminergic system in Parkinson\u2019s disease patients with impulse control disorders"],"prefix":"10.1016","volume":"18","author":[{"given":"Annamaria","family":"Vallelunga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Flaibani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Formento-Dojot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Biundo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Facchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Antonini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.parkreldis.2011.10.019_bib1","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/mds.23501","article-title":"Impulsivity and compulsivity in drug-na\u00efve patients with Parkinson\u2019s disease","volume":"26","author":"Antonini","year":"2011","journal-title":"Mov Disord"},{"issue":"Suppl. 3","key":"10.1016\/j.parkreldis.2011.10.019_bib2","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1016\/S1353-8020(09)70794-1","article-title":"Impulse control disorders in Parkinson\u2019s disease: prevalence and possible risk factors","volume":"15","author":"Weintraub","year":"2009","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"10.1016\/j.parkreldis.2011.10.019_bib3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.bcp.2007.06.043","article-title":"The neurobiology and genetics of impulse control disorders: relationships to drug addictions","volume":"75","author":"Brewer","year":"2008","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"10.1016\/j.parkreldis.2011.10.019_bib4","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/humu.20039","article-title":"Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23.1","volume":"23","author":"Neville","year":"2004","journal-title":"Hum Mutat"},{"issue":"3","key":"10.1016\/j.parkreldis.2011.10.019_bib5","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00008571-199606000-00007","article-title":"Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders","volume":"6","author":"Lachman","year":"1996","journal-title":"Pharmacogenetics"},{"issue":"4","key":"10.1016\/j.parkreldis.2011.10.019_bib6","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.neuroimage.2007.06.021","article-title":"Impact of the COMT Val108\/158Met and DAT genotypes on prefrontal function in healthy subjects","volume":"37","author":"Cald\u00fa","year":"2007","journal-title":"Neuroimage"},{"issue":"2","key":"10.1016\/j.parkreldis.2011.10.019_bib7","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/sj.tpj.6500026","article-title":"The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression","volume":"1","author":"Fuke","year":"2001","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.parkreldis.2011.10.019_bib8","series-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2000"},{"issue":"3","key":"10.1016\/j.parkreldis.2011.10.019_bib9","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J\u00a0Psychiatr Res"},{"issue":"1","key":"10.1016\/j.parkreldis.2011.10.019_bib10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1089\/gte.2006.10.31","article-title":"The VNTR polymorphism in the human dopamine transporter gene: improved detection and absence of association of VNTR alleles with attention-deficit hyperactivity disorder","volume":"10","author":"Simsek","year":"2006","journal-title":"Genet Test"},{"issue":"8","key":"10.1016\/j.parkreldis.2011.10.019_bib11","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1001\/archneur.64.8.1089","article-title":"Medication-related impulse control and repetitive behaviors in Parkinson disease","volume":"64","author":"Voon","year":"2007","journal-title":"Arch Neurol"},{"issue":"4","key":"10.1016\/j.parkreldis.2011.10.019_bib12","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.alcohol.2009.02.006","article-title":"The TaqI A DRD2 polymorphism in type II alcohol dependence: a marker of age at onset or of a familial disease?","volume":"43","author":"Pinto","year":"2009","journal-title":"Alcohol"},{"issue":"2","key":"10.1016\/j.parkreldis.2011.10.019_bib13","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1034\/j.1399-0004.2001.600204.x","article-title":"The additive effect of neurotransmitter genes in pathological gambling","volume":"60","author":"Comings","year":"2001","journal-title":"Clin Genet"}],"container-title":["Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802011003737?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802011003737?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:13:43Z","timestamp":1761178423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802011003737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S1353802011003737"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2011.10.019","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of genetic polymorphisms of the dopaminergic system in Parkinson\u2019s disease patients with impulse control disorders","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2011.10.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}